277 related articles for article (PubMed ID: 23052483)
1. Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma.
Guo XL; Li D; Sun K; Wang J; Liu Y; Song JR; Zhao QD; Zhang SS; Deng WJ; Zhao X; Wu MC; Wei LX
J Mol Med (Berl); 2013 Apr; 91(4):473-83. PubMed ID: 23052483
[TBL] [Abstract][Full Text] [Related]
2. Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy.
Selvakumaran M; Amaravadi RK; Vasilevskaya IA; O'Dwyer PJ
Clin Cancer Res; 2013 Jun; 19(11):2995-3007. PubMed ID: 23461901
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
Shimizu S; Takehara T; Hikita H; Kodama T; Tsunematsu H; Miyagi T; Hosui A; Ishida H; Tatsumi T; Kanto T; Hiramatsu N; Fujita N; Yoshimori T; Hayashi N
Int J Cancer; 2012 Aug; 131(3):548-57. PubMed ID: 21858812
[TBL] [Abstract][Full Text] [Related]
4. Propyl gallate inhibits hepatocellular carcinoma cell growth through the induction of ROS and the activation of autophagy.
Wei PL; Huang CY; Chang YJ
PLoS One; 2019; 14(1):e0210513. PubMed ID: 30653551
[TBL] [Abstract][Full Text] [Related]
5. Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression.
Xiong YQ; Sun HC; Zhu XD; Zhang W; Zhuang PY; Zhang JB; Xu HX; Kong LQ; Wu WZ; Qin LX; Tang ZY
J Cancer Res Clin Oncol; 2011 Mar; 137(3):505-12. PubMed ID: 20490863
[TBL] [Abstract][Full Text] [Related]
6. Targeted degradation of NDUFS1 by agrimol B promotes mitochondrial ROS accumulation and cytotoxic autophagy arrest in hepatocellular carcinoma.
Dong L; Luo L; Wang Z; Lian S; Wang M; Wu X; Fan J; Zeng Y; Li S; Lv S; Yang Y; Chen R; Shen E; Yang W; Li C; Wang K
Free Radic Biol Med; 2024 Aug; 220():111-124. PubMed ID: 38697493
[TBL] [Abstract][Full Text] [Related]
7. Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.
Huynh H; Chow PK; Palanisamy N; Salto-Tellez M; Goh BC; Lee CK; Somani A; Lee HS; Kalpana R; Yu K; Tan PH; Wu J; Soong R; Lee MH; Hor H; Soo KC; Toh HC; Tan P
J Hepatol; 2008 Jul; 49(1):52-60. PubMed ID: 18490075
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of p53 increases chemosensitivity to 5-FU in nutrient-deprived hepatocarcinoma cells by suppressing autophagy.
Guo XL; Hu F; Zhang SS; Zhao QD; Zong C; Ye F; Guo SW; Zhang JW; Li R; Wu MC; Wei LX
Cancer Lett; 2014 May; 346(2):278-84. PubMed ID: 24462821
[TBL] [Abstract][Full Text] [Related]
9. Metronomic chemotherapy in combination with antiangiogenic treatment induces mosaic vascular reduction and tumor growth inhibition in hepatocellular carcinoma xenografts.
Zhou F; Hu J; Shao JH; Zou SB; Shen SL; Luo ZQ
J Cancer Res Clin Oncol; 2012 Nov; 138(11):1879-90. PubMed ID: 22736027
[TBL] [Abstract][Full Text] [Related]
10. Effective inhibition of xenografts of hepatocellular carcinoma (HepG2) by rapamycin and bevacizumab in an intrahepatic model.
Ong LC; Song IC; Jin Y; Kee IH; Siew E; Yu S; Thng CH; Huynh H; Chow PK
Mol Imaging Biol; 2009; 11(5):334-42. PubMed ID: 19330383
[TBL] [Abstract][Full Text] [Related]
11. Sunitinib (SUTENT, SU11248) suppresses tumor growth and induces apoptosis in xenograft models of human hepatocellular carcinoma.
Huynh H; Ngo VC; Choo SP; Poon D; Koong HN; Thng CH; Toh HC; Zheng L; Ong LC; Jin Y; Song IC; Chang AP; Ong HS; Chung AY; Chow PK; Soo KC
Curr Cancer Drug Targets; 2009 Sep; 9(6):738-47. PubMed ID: 19754358
[TBL] [Abstract][Full Text] [Related]
12. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
[TBL] [Abstract][Full Text] [Related]
13. Combination of bevacizumab and acyclic retinoid inhibits the growth of hepatocellular carcinoma xenografts.
Kubota M; Shimizu M; Baba A; Ohno T; Kochi T; Shirakami Y; Moriwaki H
J Nutr Sci Vitaminol (Tokyo); 2014; 60(5):357-62. PubMed ID: 25744425
[TBL] [Abstract][Full Text] [Related]
14. Bevacizumab Augments the Antitumor Efficacy of Infigratinib in Hepatocellular Carcinoma.
Le TBU; Vu TC; Ho RZW; Prawira A; Wang L; Goh BC; Huynh H
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321903
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of autophagic flux by salinomycin results in anti-cancer effect in hepatocellular carcinoma cells.
Klose J; Stankov MV; Kleine M; Ramackers W; Panayotova-Dimitrova D; Jäger MD; Klempnauer J; Winkler M; Bektas H; Behrens GM; Vondran FW
PLoS One; 2014; 9(5):e95970. PubMed ID: 24816744
[TBL] [Abstract][Full Text] [Related]
16. Autophagy activation in hepatocellular carcinoma contributes to the tolerance of oxaliplatin via reactive oxygen species modulation.
Ding ZB; Hui B; Shi YH; Zhou J; Peng YF; Gu CY; Yang H; Shi GM; Ke AW; Wang XY; Song K; Dai Z; Shen YH; Fan J
Clin Cancer Res; 2011 Oct; 17(19):6229-38. PubMed ID: 21825039
[TBL] [Abstract][Full Text] [Related]
17. Novel synergistic antitumor effects of rapamycin with bortezomib on hepatocellular carcinoma cells and orthotopic tumor model.
Wang C; Gao D; Guo K; Kang X; Jiang K; Sun C; Li Y; Sun L; Shu H; Jin G; Sun H; Wu W; Liu Y
BMC Cancer; 2012 May; 12():166. PubMed ID: 22559167
[TBL] [Abstract][Full Text] [Related]
18. Anticancer and Antiangiogenic Activities of Novel α-Mangostin Glycosides in Human Hepatocellular Carcinoma Cells via Downregulation of c-Met and HIF-1α.
Kim SM; Han JM; Le TT; Sohng JK; Jung HJ
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516967
[TBL] [Abstract][Full Text] [Related]
19. Berberine increases the killing effect of pirarubicin on HCC cells by inhibiting ATG4B-autophagy pathway.
He H; He M; Wang Y; Xiong H; Xiong Y; Shan M; Liu D; Guo Z; Kou Y; Zhang Y; Yang M; Lian J; Sun L; He F
Exp Cell Res; 2024 Jun; 439(1):114094. PubMed ID: 38750718
[TBL] [Abstract][Full Text] [Related]
20. Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography.
Zhu XD; Zhang JB; Fan PL; Xiong YQ; Zhuang PY; Zhang W; Xu HX; Gao DM; Kong LQ; Wang L; Wu WZ; Tang ZY; Ding H; Sun HC
BMC Cancer; 2011 Jan; 11():28. PubMed ID: 21251271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
